ID
32919
Description
Study ID: 107085 Clinical Study ID: GLP107085 Study Title: A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01406262 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2
Keywords
Versions (1)
- 11/20/18 11/20/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 20, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
The Effect of Albiglutide on Cardiac Repolarisation Compared with Placebo 107085
Liver Biopsy Data: Liver Infections
- StudyEvent: ODM
Description
Liver Biopsy
Description
J. Liver Infections
Description
Normal
Data type
boolean
Description
Leishmaniasis Donovani
Data type
boolean
Description
Plasmodium Falciparum
Data type
boolean
Description
Taxoplasmosis
Data type
boolean
Description
Cryptococcus neoformans
Data type
boolean
Description
Histoplasma capsulatum
Data type
boolean
Description
Mycobacterium tuberculosis
Data type
boolean
Description
Other mycobacterial species
Data type
boolean
Description
Other
Data type
text
Similar models
Liver Biopsy Data: Liver Infections
- StudyEvent: ODM